New scan could help doctors choose best treatment for kidney tumors
NCT ID NCT03996850
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a special type of scan called SPECT/CT can help doctors make better decisions about treating kidney tumors. The scan uses a radioactive tracer to see how tumors behave. Researchers will check if the scan changes what doctors recommend for 102 patients with new kidney tumors. The goal is to see if this less invasive method can guide treatment choices.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Technetium Tc-99m sestamibi (a radioactive tracer used in imaging)
What this could lead to
If successful, this imaging method could help doctors decide on the best treatment for kidney tumors without needing invasive biopsies.
What could go wrong
This is an early-stage study focused on decision-making, not treatment outcomes. The imaging may not change decisions as expected, and results may not apply to all kidney tumor types.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY NEOPLASM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California, 90095, United States